support to communities, and make sure more shots get in arms. so the administration now begins a seven-week sprint to open vaccine access to all american adults by may 1st. cdc reports 100 million doses of the three approved vaccines have been given out. white house announced latest plan to get more shots into arms. over the coming weeks we ll deliver vaccines directly, up to 700 additional community health centers that reach underserved communities. we ll work to double the number of pharmacies participating in the federal pharmacy program. we will make the vaccine available at more than 20,000 pharmacies across america. now to a big unraveling story in world of politics, new york governor andrew cuomo who drew national attention for handling of the pandemic early on, facing a growing pressure campaign over allegations of sexual harassment and inappropriate behavior on the job. seven women have now accused cuomo of misconduct. both new york senators and majority of the
this landmark legislation will get relief to families, get support to communities, and make sure more shots get in arms. so the administration now begins a seven-week sprint to open vaccine access to all american adults by may 1st. cdc reports 100 million doses of the three approved vaccines have been given out. white house announced latest plan to get more shots into arms. over the coming weeks we ll deliver vaccines directly, up to 700 additional community health centers that reach underserved communities. we ll work to double the number of pharmacies participating in the federal pharmacy program. we will make the vaccine available at more than 20,000 pharmacies across america. now to a big unraveling story in world of politics, new york governor andrew cuomo who drew national attention for handling of the pandemic early on, facing a growing pressure campaign over allegations of sexual harassment and inappropriate behavior on the job. seven women have now accused cuom
GlaxoSmithKline Pharmaceuticals (GSK India) on Wednesday reported 13% year-on-year (YoY) jump of net profit to Rs 131 crore for the quarter ended June 2023 led by robust volumes, price hikes and recovery of its vaccine business. The said it maintained its gross margins despite the National List of Essential Medicines (NLEM) impact, while EBITDA margins declined 1% to 19.1% on account of new product launch investments led by Shingrix.
Takeda Pharmaceutical (TAK) Announces Approval of QDENGA in Indonesia streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.